Why the study?
Do direct thrombin inhibitors (hirudin and hirulog) provide better efficacy and safety compared to heparin in patients requiring antithrombotic therapy?
Population
Patients requiring antithrombotic therapy for unstable angina, coronary angioplasty, major orthopedic…
Comparison
Hirudin and hirulog (direct thrombin inhibitors) vs Heparin
Design
Review
Authors
Loading...
Requires confirmation in larger randomized trials before clinical adoption; hypothesis-generating for antithrombotic optimization.
Do direct thrombin inhibitors (hirudin and hirulog) provide better efficacy and safety compared to heparin in patients requiring antithrombotic therapy?
Direct thrombin inhibitors like hirudin and hirulog show potential advantages over heparin, including better efficacy and fewer bleeding complications, for various cardiovascular and thrombotic indications.
Paul H. Johnson (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: